NO985340L - Mikropartikler og deres anvendelse ved sÕrbehandling - Google Patents

Mikropartikler og deres anvendelse ved sÕrbehandling

Info

Publication number
NO985340L
NO985340L NO985340A NO985340A NO985340L NO 985340 L NO985340 L NO 985340L NO 985340 A NO985340 A NO 985340A NO 985340 A NO985340 A NO 985340A NO 985340 L NO985340 L NO 985340L
Authority
NO
Norway
Prior art keywords
microparticles
wound care
care
wound
Prior art date
Application number
NO985340A
Other languages
English (en)
Other versions
NO985340D0 (no
Inventor
David Heath
Sarah Margaret Middleton
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9610340.3A external-priority patent/GB9610340D0/en
Priority claimed from GBGB9615436.4A external-priority patent/GB9615436D0/en
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of NO985340D0 publication Critical patent/NO985340D0/no
Publication of NO985340L publication Critical patent/NO985340L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
NO985340A 1996-05-17 1998-11-16 Mikropartikler og deres anvendelse ved sÕrbehandling NO985340L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9610340.3A GB9610340D0 (en) 1996-05-17 1996-05-17 Spray-dried products and their therapeutic use
GBGB9615436.4A GB9615436D0 (en) 1996-07-23 1996-07-23 Spray-dried products and their therapeutic use
PCT/GB1997/001308 WO1997044015A1 (en) 1996-05-17 1997-05-14 Microparticles and their use in wound therapy
US08/858,814 US6113948A (en) 1996-05-17 1997-05-19 Microparticles and their use in wound therapy

Publications (2)

Publication Number Publication Date
NO985340D0 NO985340D0 (no) 1998-11-16
NO985340L true NO985340L (no) 1999-01-18

Family

ID=27268285

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985340A NO985340L (no) 1996-05-17 1998-11-16 Mikropartikler og deres anvendelse ved sÕrbehandling

Country Status (6)

Country Link
US (1) US6113948A (no)
EP (1) EP0914096B1 (no)
JP (1) JP4024302B2 (no)
AU (1) AU702955B2 (no)
NO (1) NO985340L (no)
WO (1) WO1997044015A1 (no)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
GB9610830D0 (en) 1996-05-23 1996-07-31 Andaris Ltd Use of hollow microcapsules
WO1998055105A1 (en) 1997-06-05 1998-12-10 Hemosphere, Inc. Fibrinogen-coated microspheres
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
WO1999042146A1 (en) * 1998-02-20 1999-08-26 Quadrant Healthcare (Uk) Limited Products comprising fibrinogen for use in therapy
JP3578627B2 (ja) * 1998-05-15 2004-10-20 株式会社ホギメディカル 創傷患部の治癒を促進する組織シーラント
DE19849589C1 (de) * 1998-10-27 2000-06-15 Glatt Process Technology Gmbh Fibrin-Gewebekleber-Formulierung und Verfahren zu dessen Herstellung
US7572769B2 (en) 1998-12-23 2009-08-11 Csl Behring Gmbh Fibrin adhesive granulate and method for its preparation
DE19859611C2 (de) * 1998-12-23 2003-07-03 Aventis Behring Gmbh Fibrinklebergranulat und Verfahren zu dessen Herstellung
KR100804434B1 (ko) * 1998-12-23 2008-02-20 체에스엘 베링 게엠베하 피브린계 접착제 과립 및 이의 제조방법
ATE555773T1 (de) 1999-06-09 2012-05-15 Sievers Robert E Überkritische fluidgestützte verneblung und blasen trochnen
DE19962221A1 (de) * 1999-10-01 2001-05-23 Glatt Process Technology Gmbh Dispersionen für Depotapplikationen
JP3576063B2 (ja) 2000-02-22 2004-10-13 株式会社ホギメディカル 凝固蛋白質を含む可溶性創傷治癒止血セルロース繊維とその製造方法
ES2525087T5 (es) 2000-05-10 2018-06-28 Novartis Ag Polvos basados en fosfolípidos para administración de fármacos
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US20040126900A1 (en) * 2001-04-13 2004-07-01 Barry Stephen E High affinity peptide- containing nanoparticles
DE60235462D1 (de) * 2001-05-09 2010-04-08 Biointeractions Ltd Wundverschlusssystem und verfahren
US6552172B2 (en) * 2001-08-30 2003-04-22 Habto Biotech, Inc. Fibrin nanoparticles and uses thereof
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
NL1019873C2 (nl) * 2002-01-31 2003-08-04 Harimex Bv Werkwijze voor het bereiden van een bloedplasmapoeder, en toepassingen hiervan.
CA2545874C (en) 2003-10-06 2012-02-21 3F Therapeutics, Inc. Minimally invasive valve replacement system
US20050075720A1 (en) 2003-10-06 2005-04-07 Nguyen Tuoc Tan Minimally invasive valve replacement system
US8277837B2 (en) 2006-01-11 2012-10-02 Entegrion, Inc. Hemostatic textile
US20160106883A1 (en) * 2014-10-15 2016-04-21 Stb, Ltd. Processes For Mixing Fibrinogen and Thrombin Under Conditions That Minimize Fibrin Formation While Preserving Fibrin-forming Ability, Compositions Produced by These Processes, and the Use Thereof
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
WO2009020612A1 (en) * 2007-08-06 2009-02-12 Stb Lifesaving Technologies, Inc. Methods and dressing for sealing internal injuries
US20090053288A1 (en) * 2007-08-20 2009-02-26 Eskridge Jr E Stan Hemostatic woven fabric
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
US9827205B2 (en) * 2008-12-12 2017-11-28 Mallinckrodt Pharma Ip Trading D.A.C. Dry powder fibrin sealant
EP2216054A1 (en) 2009-02-06 2010-08-11 ProFibrix BV Biodegradable extravascular support
GB0909131D0 (en) 2009-05-28 2009-07-01 Quadrant Drug Delivery Ltd Dry powder fibrin sealant
PL2435028T3 (pl) * 2009-05-28 2017-09-29 Profibrix Bv Uszczelniacz fibrynowy w postaci suchego proszku
GB0909136D0 (en) * 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition
GB0909129D0 (en) * 2009-05-28 2009-07-01 Quadrant Drug Delivery Ltd Dry powder fibrin sealant
DK2521566T3 (en) 2010-01-08 2014-12-08 Profibrix Bv Fibrinogen preparations enriched with fibrinogen with an extended alpha chain
WO2011083154A1 (en) 2010-01-08 2011-07-14 Profibrix Bv Dry powder fibrin sealant
JP2013522246A (ja) 2010-03-15 2013-06-13 フェロサン メディカル デバイシーズ エイ／エス 止血および／または創傷治癒を促進するための方法
ES2676208T3 (es) 2010-06-01 2018-07-17 Baxter International Inc. Proceso para la producción de composiciones hemostáticas secas y estables
GB201101740D0 (en) 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
JP6195569B2 (ja) * 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
GB201201751D0 (en) 2012-02-01 2012-03-14 Haemostatix Ltd Haemostatic wound dressing
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
WO2014022685A1 (en) 2012-08-03 2014-02-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Recruitment of mesenchymal cells using controlled release systems
US20140220136A1 (en) * 2013-02-05 2014-08-07 Bordoloi Biotech, Llc System and method for delivering protease inhibitors
JP2016510059A (ja) * 2013-03-07 2016-04-04 プロフィブリックス・ベーフェー 粉末製剤
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
EP3013294B1 (en) 2013-06-28 2019-09-25 3M Innovative Properties Company Fibrin-coated wound dressing
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
AU2015333206B2 (en) 2014-10-13 2019-07-11 Ferrosan Medical Devices A/S. Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
WO2016160541A1 (en) 2015-03-27 2016-10-06 3M Innovative Properties Company Fibrin composition, method and wound articles
US9861597B2 (en) 2015-05-19 2018-01-09 Penn State Research Foundation Gluconate-based compositions as a neonate anticonvulsant
WO2016198351A1 (en) * 2015-06-10 2016-12-15 Evonik Röhm Gmbh Process for preparing a powder comprising a human coagulation factor protein and a lactic acid polymer
CN107771093B (zh) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 用于混合两种组分和用于在存储条件下保持真空的注射器
IL242984A0 (en) * 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
KR102576293B1 (ko) 2015-11-06 2023-09-08 에디컨인코포레이티드 압밀된 지혈 셀룰로오스 집합체
US11530394B2 (en) 2016-03-15 2022-12-20 University Of Massachusetts Anti-CRISPR compounds and methods of use
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
US11413335B2 (en) 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
WO2018067628A1 (en) 2016-10-05 2018-04-12 3M Innovative Properties Company Fibrin composition comprising carrier material, method and wound articles
EP3522941A4 (en) 2016-10-05 2020-06-17 3M Innovative Properties Company FIBRINOGEN COMPOSITION, METHOD AND ARTICLES FOR WOUNDS
EP3735262A4 (en) 2018-01-03 2021-09-29 Penn State Research Foundation GLUCOSE OXIDASE COMPOSITIONS AS ANTICONVULSIVE FOR NEWBORN
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
WO2023283246A1 (en) 2021-07-09 2023-01-12 University Of Massachusetts Modular prime editor systems for genome engineering
WO2023018705A1 (en) 2021-08-10 2023-02-16 University Of Massachusetts Compositions and methods for sirna treatment of muscular dystrophy
WO2023115427A1 (en) 2021-12-23 2023-06-29 Guangzhou Bioseal Biotech Co., Ltd. Spray dried thrombin
EP4544044A2 (en) 2022-07-25 2025-04-30 University of Massachusetts Nucleic acid antisense oligomer readthrough of nonsense codons
JP2025534869A (ja) * 2022-09-30 2025-10-20 フェロサン メディカル デバイシーズ エイ／エス 止血用組成物
CN121399470A (zh) 2023-05-03 2026-01-23 马尼福尔德生物技术有限公司 用于高通量蛋白质递送、筛选和检测的方法和组合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565559A (en) * 1968-03-11 1971-02-23 Sumitomo Chemical Co Process for making microcapsules
US3960583A (en) * 1974-05-02 1976-06-01 Philadelphia Quartz Company Method of preparing modified hollow, largely spherical particles by spray drying
DE3171072D1 (en) * 1981-06-25 1985-07-25 Stroetmann M Serapharm Enriched plasma derivative for promoting wound sealing and wound covering
EP0086627B1 (en) * 1982-02-12 1985-08-28 Unitika Ltd. Anti-cancer device
JPS60214728A (ja) * 1984-04-06 1985-10-28 Unitika Ltd 生理活性物質徐放性材料
JPS6144825A (ja) * 1984-08-09 1986-03-04 Unitika Ltd 止血剤
NL8500774A (nl) * 1985-03-18 1986-10-16 Dagra Nv Werkwijze ter bereiding van een vrij vloeiend, homogeen povidonjood wondpoeder.
US4752466A (en) * 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
JPH03201982A (ja) * 1989-12-29 1991-09-03 Sakai Chem Ind Co Ltd 固定化トロンビン、その製法および止血用製剤
GB9003821D0 (en) * 1990-02-20 1990-04-18 Danbiosyst Uk Diagnostic aid
JPH0813750B2 (ja) * 1990-03-01 1996-02-14 持田製薬株式会社 経口用トロンビン製剤
DK0494417T3 (da) * 1991-01-10 1996-05-13 Basf Corp Fremgangsmåde til tværbinding af gelatine og til inkorporering af et materiale deri
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
WO1992013495A1 (en) * 1991-02-07 1992-08-20 Fibratek, Inc. Fibrinogen based adhesive
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
ES2245780T3 (es) * 1994-05-18 2006-01-16 Nektar Therapeutics Metodos y composiciones para la formulacion de interferones como un polvo seco.
JPH0853365A (ja) * 1994-08-09 1996-02-27 Ss Pharmaceut Co Ltd 経口用トロンビン製剤
PL319600A1 (en) * 1994-09-29 1997-08-18 Andaris Ltd Spray-dried microparticles as therapeutic carriers
PT796090E (pt) * 1994-12-16 2003-07-31 Elan Drug Delivery Ltd Microparticulas reticuladas e sua utilizacao como veiculos terapeuticos

Also Published As

Publication number Publication date
NO985340D0 (no) 1998-11-16
WO1997044015A1 (en) 1997-11-27
JP4024302B2 (ja) 2007-12-19
EP0914096B1 (en) 2003-08-13
JP2000511169A (ja) 2000-08-29
AU2783797A (en) 1997-12-09
US6113948A (en) 2000-09-05
AU702955B2 (en) 1999-03-11
EP0914096A1 (en) 1999-05-12

Similar Documents

Publication Publication Date Title
NO985340L (no) Mikropartikler og deres anvendelse ved sÕrbehandling
NO20001639D0 (no) Kollodiale borosilikater og anvendelse derav ved papirfremstilling
NO964958D0 (no) Aluminium-scandiumlegeringer og deres anvendelse
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
IS4481A (is) Díhýdrópyramídín og notkun þeirra
NO972983L (no) Sulfonamider og deres anvendelse
BR9702553A (pt) Composição cosmética e utilização
IS6411A (is) Kaspasa tálmar og notkun þeirra
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
DE69836432D1 (de) Bildcoder und -decoder
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
NO984836L (no) Substituerte benzylaminer og deres anvendelse for behandling av depresjon
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
NO992310D0 (no) Inhibitorer og deres anvendelse i oljer
DK0878186T3 (da) Kosmetiske detergentpræparater og deres anvendelse
NO990303L (no) Lipidbindende proteiner og deres terapeutiske og diagnostiske anvendelse
NO970165D0 (no) Kortikotropin frigivningsfaktor-bindingsprotein inhibitorer og deres anvendelse
NO20015906L (no) Spleisosomprotein og dets anvendelse
BR7701849U (pt) Disposição introduzida em banco coletivo e similares
KR970051241U (ko) 우산 겸용 파라솔
NO20014300L (no) Nytt protein og dets anvendelse
KR970053607U (ko) 외발스키형 스케이트 보드 및 폴
KR960020229U (ko) 휴대용 장기판겸 바둑판

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application